Once the FDA approved the treatment of the world's priciest drug, the conversation over the cost of "miracle" treatments reignited. But for those who will benefit, there is no debate. In other pharmaceutical news: a look at this year's big bioconference, President Donald Trump's drug pricing agenda, CVS' defense of its Aetna deal, and more.

from Kaiser Health News http://bit.ly/3155Zs3

Related Posts:

0 comments:

Post a Comment

Popular Posts